These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2866801

  • 1. [Changes in the sensitivity of brain dopamine and serotonin receptors during the prolonged administration of carbidine].
    Zharkovskiĭ AM, Chereshka KS, Zharkovskaia TA, Allikmets LKh.
    Biull Eksp Biol Med; 1985 Dec; 100(12):719-22. PubMed ID: 2866801
    [Abstract] [Full Text] [Related]

  • 2. [Effect of carbidine on the dopamine and serotonin receptors of the central nervous system].
    Zharkovskiĭ AM, Klassen NE, Zharkovskiĭ TA.
    Biull Eksp Biol Med; 1985 Jun; 99(6):700-2. PubMed ID: 2861866
    [Abstract] [Full Text] [Related]

  • 3. [Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats].
    Miroshnichenko II, Kudrin VS, Raevskiĭ KS.
    Farmakol Toksikol; 1988 Jun; 51(2):26-9. PubMed ID: 2897932
    [Abstract] [Full Text] [Related]

  • 4. [Role of serotonin and dopamine receptors in the mechanism of action of haloperidol and pirenperone].
    Maĭmets MO, Vasar EE, Nurk AM, Allikmets LKh.
    Farmakol Toksikol; 1985 Jun; 48(2):15-8. PubMed ID: 3996566
    [Abstract] [Full Text] [Related]

  • 5. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ, Gobert A, Newman-Tancredi A, Audinot V, Lejeune F, Rivet JM, Cussac D, Nicolas JP, Muller O, Lavielle G.
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [Abstract] [Full Text] [Related]

  • 6. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS, Hetey L, Morgenshtern R, Raevskiĭ KS, Olssner W.
    Farmakol Toksikol; 1987 Sep; 50(2):16-20. PubMed ID: 2884129
    [Abstract] [Full Text] [Related]

  • 7. Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
    Bacopoulos NG.
    J Pharmacol Exp Ther; 1981 Dec; 219(3):708-14. PubMed ID: 6170752
    [Abstract] [Full Text] [Related]

  • 8. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
    Zharkovskiĭ AM, Allikmets LKh, Nurk AM.
    Farmakol Toksikol; 1982 Dec; 45(1):10-2. PubMed ID: 7198997
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of 2-(4-ethyl-1-piperazinyl)-4-(fluorophenyl)-5,6,7,8,9, 10-hexahydrocycloocta[b]pyridine (AD-5423) and haloperidol for their pharmacological activities related to antipsychotic efficacy and/or adverse side-effects.
    Noda Y, Kurumiya S, Miura Y, Oka M.
    J Pharmacol Exp Ther; 1993 May; 265(2):745-51. PubMed ID: 8098763
    [Abstract] [Full Text] [Related]

  • 10. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
    Gulati A, Srimal RC, Dhawan BN.
    Pharmacology; 1988 May; 36(6):396-404. PubMed ID: 2901759
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
    Oka M, Noda Y, Ochi Y, Furukawa K, Une T, Kurumiya S, Hino K, Karasawa T.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
    [Abstract] [Full Text] [Related]

  • 12. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J, Devanand DP, Carey RJ.
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [Abstract] [Full Text] [Related]

  • 13. [Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration].
    Zharkovskiĭ AM, Riago LK, Arro AG.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1980 Nov; 30(1):165-8. PubMed ID: 7189932
    [Abstract] [Full Text] [Related]

  • 14. [Relationship of the homovanillic acid content in the rat brain after the administration of a neuroleptic and the degree of dopamine receptor sensitivity to an agonist].
    Zharkovskiĭ AM, Allikmets LKh, Otter MIa.
    Biull Eksp Biol Med; 1979 Jun; 87(6):559-60. PubMed ID: 572714
    [Abstract] [Full Text] [Related]

  • 15. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Kumagai T, Nakazato A, Nagamine M, Yamaguchi K, Tomisawa K.
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE, Iorio LC, Coffin VL, McQuade RD, Berger JG, Barnett A.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [Abstract] [Full Text] [Related]

  • 17. [Effect of an imidazobenzodiazepine (RO 15-1788) on aggressive behavior in mice].
    Vasar EE, Maĭmets MO, Riago LK, Nurk AM, Allikmets LKh.
    Biull Eksp Biol Med; 1984 Oct; 98(10):441-3. PubMed ID: 6208949
    [Abstract] [Full Text] [Related]

  • 18. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
    Matsubara R.
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
    [Abstract] [Full Text] [Related]

  • 19. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
    Surmann A, Havemann-Reinecke U.
    J Neural Transm Suppl; 1995 Jul; 45():143-55. PubMed ID: 8748620
    [Abstract] [Full Text] [Related]

  • 20. Possible role of brain serotonin and dopamine in controlling male sexual behavior.
    Gessa GL, Tagliamonte A.
    Adv Biochem Psychopharmacol; 1974 Jul; 11(0):217-28. PubMed ID: 4276859
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.